v3.25.2
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Dec. 31, 2022
Operating Activities      
Net income $ 9,626 $ 9,155 $ 8,978
Depreciation and amortization 3,160 2,948 2,763
Gain associated with the Juice Transaction 0 0 (3,321)
Impairment and other charges 714 1,230 3,618
Indirect tax impact 218 0 0
Product recall-related impact 187 136 0
Payments for product recall-related impact (148) 0 0
Operating lease right-of-use asset amortization 655 570 517
Share-based compensation expense 362 380 343
Restructuring and impairment charges 727 445 411
Cash payments for restructuring charges (436) (434) (224)
Pension and retiree medical plan expense 414 150 419
Pension and retiree medical plan contributions (348) (410) (384)
Deferred income taxes and other tax charges and credits (42) (271) (873)
Tax expense related to the TCJ Act 0 0 86
Tax payments related to the TCJ Act (579) (309) (309)
Change in assets and liabilities [Abstract]      
Accounts and notes receivable (138) (793) (1,763)
Inventories (314) (261) (1,142)
Prepaid expenses and other current assets 40 (13) 118
Accounts payable and other current liabilities (1,161) 420 1,842
Income taxes payable (123) 310 57
Other, net (307) 189 (325)
Net Cash Provided by Operating Activities 12,507 13,442 10,811
Investing Activities      
Capital spending (5,318) (5,518) (5,207)
Sales of property, plant and equipment 342 198 251
Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets (256) (314) (873)
Proceeds associated with the Juice Transaction 0 0 3,456
Other divestitures, sales of investments in noncontrolled affiliates and other assets 166 75 49
Short-term investments, by original maturity:      
More than three months - purchases (425) (555) (291)
More than three months - maturities 0 556 150
More than three months - Sales 0 12 0
Three months or less, net 5 3 24
Other investing, net 14 48 11
Net Cash Used for Investing Activities (5,472) (5,495) (2,430)
Financing Activities      
Proceeds from issuances of long-term debt 4,042 5,482 3,377
Payments of long-term debt (3,886) (3,005) (2,458)
Debt redemptions 0 0 (1,716)
Short-term borrowings, by original maturity      
More than three months - proceeds 5,786 5,428 1,969
More than three months - payments (5,639) (3,106) (1,951)
Three months or less, net 392 (29) (31)
Cash dividends paid (7,229) (6,682) (6,172)
Share repurchases - common (1,000) (1,000) (1,500)
Proceeds from exercises of stock options 166 116 138
Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted (135) (140) (107)
Other financing (53) (73) (72)
Net Cash Used for Financing Activities (7,556) (3,009) (8,523)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (687) (277) (465)
Net (Decrease)/Increase in Cash and Cash Equivalents and Restricted Cash (1,208) 4,661 (607)
Cash and cash equivalents and restricted cash $ 8,553 $ 9,761 $ 5,100